A subscription to JoVE is required to view this content. Sign in or start your free trial.
10,820 Views
•
13:47 min
•
April 23, 2012
DOI:
Summary
Automatically generated
在这里，我们描述只对细胞的感染，从而提高重组细小的生产效率超过100倍相比，在使用中的其他协议为基础的协议。此协议依赖于使用一种新型腺病毒含有的细小副总裁转录单位（AD-VP）5，基于辅助。
Explore More Videos
Recombinant ParvovirusAdenovirus-derived SystemsRodent ParvovirusesPV GenomePromoters P4 And P38Non-structural Proteins (NS1 And NS2)Capsid Proteins (VP1 And VP2)Anticancer AgentsOncolytic AbilitiesOncosuppressive AbilitiesNS1 CytotoxicityTherapeutic TransgeneRecPVs VectorViral DNA AmplificationPackagingProducer Cells (HEK293T)PCMV-VP VectorReplication DefectiveOncotoxic ActivitiesAnti-cancer Agents
Read Article
Cite this Article
El-Andaloussi, N., Leuchs, B., Bonifati, S., Rommelaere, J., Marchini, A. Efficient Recombinant Parvovirus Production with the Help of Adenovirus-derived Systems. J. Vis. Exp. (62), e3518, doi:10.3791/3518 (2012).
Copy